Use of proton pump inhibitors and risk of hip/femur fracture:a population-based case-control study

UNLABELLED: Previous studies evaluated the association between proton pump inhibitor (PPI) use and subsequent fracture risk, but they showed ambiguous results. Therefore, the objective was to evaluate this association in a different study population. Our findings show that there is probably no causal relationship between PPI use and hip fracture risk. INTRODUCTION: Previous studies evaluated the association between PPI use and subsequent fracture risk, but they showed ambiguous results. To further test these conflicting results, the objective of this study was to evaluate the association betwe... Mehr ...

Verfasser: Pouwels, S
Lalmohamed, A
Souverein, P
Cooper, C
Veldt, B J
Leufkens, H G
de Boer, A
van Staa, T
de Vries, F
Dokumenttyp: Artikel
Erscheinungsdatum: 2011
Reihe/Periodikum: Pouwels , S , Lalmohamed , A , Souverein , P , Cooper , C , Veldt , B J , Leufkens , H G , de Boer , A , van Staa , T & de Vries , F 2011 , ' Use of proton pump inhibitors and risk of hip/femur fracture : a population-based case-control study ' , Osteoporosis International , vol. 22 , no. 3 , pp. 903-10 . https://doi.org/10.1007/s00198-010-1337-8
Schlagwörter: Aged / Case-Control Studies / Dose-Response Relationship / Drug / Female / Femoral Fractures/chemically induced / Hip Fractures/chemically induced / Histamine H2 Antagonists/administration & dosage / Humans / Male / Netherlands/epidemiology / Proton Pump Inhibitors/administration & dosage / Risk Factors
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-26822215
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://cris.maastrichtuniversity.nl/en/publications/e6b20adc-9ec6-43a0-be21-b7bc166953b5